Sam studied chemistry at Reading University and has a BSc, MSc (Distinction) and PhD, and in 2017 she also completed an MBA (Distinction) at Warwick University. Sam is a member of the Royal Society of Chemistry and a Visiting Research Fellow at Reading University.
Sam has held several roles at the Agency including Business Transformation Director, Deputy Director for Inspection, Enforcement and Standards Division and the Scientific Director of the British Pharmacopoeia (BP) Commission, with responsibility for the BP and Laboratory Services Group. Sam also worked within the Inspectorate for several years, performing inspections, nationally and overseas. Prior to joining the Agency in 2006, Sam started her career in industry, primarily across a number of Contract Research Organisations and manufacturing sites undertaking a variety of senior scientific and quality assurance roles.
Director of Inspection, Enforcement and Standards
The inspection, enforcement and standards division inspects manufacturers, wholesale dealers and importers of medicines to check they are meeting our standards. They also inspect clinical trials and toxicology labs.
They investigate when we receive reports of illegal advertising, production or sale of medicines for human use, which can result in legal action being taken. We also monitor the import of unlicensed medicines.
We are responsible for testing services in the agency, to determine whether or not materials and products are medicines, which would need to be regulated.
We are responsible for the British Pharmacopoeia (BP); an annually published book that makes an important contribution to protecting public health by providing authoritative quality standards for UK pharmaceutical substances and medicinal products.